Moderna (MRNA) plans to slash around 10% of its global workforce by the end of this year, driven by an ongoing slump in sales for its Covid vaccine, CNBC reported Thursday, citing a company memo to employees.
Moderna did not immediately reply to a request for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)